- cafead   May 19, 2022 at 12:42: AM
via Following reports of rebounding COVID-19 symptoms in people who took Pfizer's antiviral Paxlovid, the National Institutes of Health and the company are discussing testing a longer course of the antiviral, White House chief medical officer Dr. Anthony Fauci said on Wednesday.
article source
article source